CONTINUUS Team meets FDA - CONTINUUS Pharmaceuticals

The CONTINUUS Team has met with key FDA representatives for a progress update on the implementation of our end-to-end Integrated Continuous Manufacturing (ICM) process.  The picture below includes (from the left) Sap Chattopadhyay, Stephen Born, Salvatore Mascia, Bayan Takizawa, Vida Arya, Christopher Testa and Chuntian Hu.

Comments are closed.